Delivery Order SPE2DB20D3103-SPE2DB23FP0V2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide YERVOY 50 MG/10 ML VIAL 10ML. The $11,435.46 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,786.90 firm fixed price delivery order contract is for the provision of YERVOY 200 MG/40 ML VIAL 40ML, a medication, to support federal medical supply requirements. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $202,254.40 firm fixed-price delivery order contract is for the supply of YERVOY 200 MG/40 ML VIAL 40ML, a specialty medication. The contract is not set aside and has an ultimate completion date of July 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,915.98, is for the supply of YERVOY 200 MG/40 ML VIAL 40ML, a specialty medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,992.50 firm fixed-price delivery order is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a specialty medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,811.72 firm fixed price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division to supply 4564881403 ! YERVOY 50 MG/10 ML VIAL 10ML. This order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YERVOY 200 MG/40 ML VIAL 40ML, a pharmaceutical product. The contract has a ceiling value of $22,957.99 and a period of performance through June 9, 2025. This award is not set aside and was competitively awarded. AmerisourceBergen Drug Corp is the prime contractor...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563875830 YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The delivery order has a potential value of $18,459.12 and a completion date of March 27, 2024. This order is placed under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,435.46, is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a prescription medication, with a ceiling value of $22,870.92 and a performance period ending on July 14, 2025. The contract is a firm fixed-price delivery order, which means the price is set and not subject to adjustment. This award is not...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP0V2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $125,366.76 firm fixed-price delivery order is for the supply of 4561569225 - YERVOY 200 MG/40 ML VIALS 40ML, with a completion date of August 11, 2023. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this award. The contract aligns with the DLA's mission to provide medical commodities, including specialty medications, vaccines, and other essential medical products, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $125.4k | 7/21/23 |